FDA Proposed Rule to Significantly Reduce Nicotine in Tobacco Products

Dec.13.2024

FDA proposes rule to drastically reduce nicotine in tobacco products as Biden administration nears end, aiming to reduce addiction.

According to a report by CNN on December 11th, the U.S. Food and Drug Administration (FDA) has submitted a proposed rule aimed at significantly reducing the nicotine content in tobacco products as the Biden administration's term comes to an end.

The FDA first hinted at its intention to limit nicotine content in 2018. In 2022, FDA Commissioner Dr. Robert Califf announced that the agency is developing a rule that would require tobacco companies to lower the nicotine content in cigarettes.

On Tuesday (10), the FDA submitted its proposal to the Office of Management and Budget. The FDA told CNN on Wednesday (11), "Establishing a maximum nicotine content standard to reduce the addictiveness of cigarettes and certain combustible tobacco products, when finalized, will be one of the most impactful actions in the history of tobacco product regulation in the United States.

The CEO of the American Lung Association, Harold Wimmer, expressed appreciation for the initiative.

Once this rule is finalized, it could change our country's efforts to eliminate tobacco use. Making tobacco products less addictive will greatly reduce the number of young people becoming addicted. Additionally, reducing the nicotine content in all commercial tobacco products, including e-cigarettes, is crucial.

Dr. Rose Marie Robertson, Deputy Chief Science and Medical Officer of the Heart Association, pointed out that even with restricted nicotine levels, not all smokers will quit as a result.

CNN has pointed out that the approval process may take several months, and the tobacco industry typically sues the government to prevent new regulations.

References:

[1] In Biden administration’s final days, FDA advances proposal to set a nicotine limit on tobacco products

Also Read:

[1] FDA Efforts Lead to Record Decline in Youth Tobacco Use

[2] FDA Slaps Fines on 18 Retailers Over Unauthorized E-Cigarette Sales

[3] U.S. Supreme Court to Hear Vape Ban Case; Former FDA Deputy Commissioner Joins Vape Industry's Defense

#North America #United States #Traditional tobacco #Regulation

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

RLX Technology Inc. (NYSE: RLX) Q3 2025 Financial Results: Net Revenue US$158.6 Million; International Business Accounts for 72%

RLX Technology Inc. (NYSE: RLX) announced its unaudited financial results for the third quarter of 2025. The company reported net revenue of RMB 1.13 billion, up 49.3% year-on-year, and adjusted net profit of RMB 295.4 million, up 1.4% quarter-on-quarter. International business contributed 72% of total revenue, reflecting robust financial performance and continued shareholder returns.

Nov.14

Over 179,000 E-Cigarettes Destroyed in Samut Prakan as Thai Government Tightens Enforcement

Thailand’s Office of the Prime Minister, led by Minister Santi Piyatat, has destroyed nearly 179,000 confiscated e-cigarettes and accessories worth 33 million baht (approx. USD 1,020,000) as part of the government’s ongoing campaign for a “Vape-Free Thai Society.”Officials said the action demonstrates Thailand’s strict enforcement of anti-vaping laws and its commitment to protecting youth and public health.

Nov.27 by 2FIRSTS.ai

Azerbaijan’s Milli Majlis passes final reading bill banning e-cigarettes and their components

Azerbaijan’s Milli Majlis adopted in final reading a bill banning the import, export, production, storage, wholesale and retail sale, and use of electronic cigarettes and their components, through amendments to the law On Tobacco and Tobacco Products. The document states that nicotine-containing electronic cigarettes are included within the concept of tobacco products and sets out a definition of electronic cigarettes.

Dec.31 by 2FIRSTS.ai

U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency

The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.